A systematic review and meta-analysis evaluated the association between corticosteroid therapy, mortality, and infectious complications in adults with severe non-COVID-19 pneumonia or acute respiratory distress syndrome (ARDS). The review found that adjunct corticosteroids probably reduce short-term mortality in cases of severe pneumonia and ARDS and may reduce secondary shock in severe pneumonia. The findings are published in Annals of Internal Medicine.
Getting Started is Easy and Yes It's FREE
What is The Ecosystem?
The Token Revolution.
The Next Bitcoin Moment.
